Yang et al., 2021 - Google Patents
A modular synthetic route involving N-aryl-2-nitrosoaniline intermediates leads to a new series of 3-substituted halogenated phenazine antibacterial agentsYang et al., 2021
View PDF- Document ID
- 8999364671738243798
- Author
- Yang H
- Kundra S
- Chojnacki M
- Liu K
- Fuse M
- Abouelhassan Y
- Kallifidas D
- Zhang P
- Huang G
- Jin S
- Ding Y
- Luesch H
- Rohde K
- Dunman P
- Lemos J
- Huigens III R
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
Pathogenic bacteria demonstrate incredible abilities to evade conventional antibiotics through the development of resistance and formation of dormant, surface-attached biofilms. Therefore, agents that target and eradicate planktonic and biofilm bacteria are of significant …
- 239000003242 anti bacterial agent 0 title abstract description 76
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yang et al. | A modular synthetic route involving N-aryl-2-nitrosoaniline intermediates leads to a new series of 3-substituted halogenated phenazine antibacterial agents | |
| Garrison et al. | Structure–activity relationships of a diverse class of halogenated phenazines that targets persistent, antibiotic-tolerant bacterial biofilms and Mycobacterium tuberculosis | |
| Song et al. | A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens | |
| Qu et al. | A new coumarin compound DCH combats methicillin-resistant Staphylococcus aureus biofilm by targeting arginine repressor | |
| Ghosh et al. | Targeted antibiotic delivery: selective siderophore conjugation with daptomycin confers potent activity against multidrug resistant Acinetobacter baumannii both in vitro and in vivo | |
| Casciaro et al. | Inhibition of Pseudomonas aeruginosa biofilm formation and expression of virulence genes by selective epimerization in the peptide Esculentin‐1a (1‐21) NH 2 | |
| Chen et al. | A marine antibiotic kills multidrug-resistant bacteria without detectable high-level resistance | |
| Reens et al. | A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load | |
| Liu et al. | Modular synthetic routes to fluorine-containing halogenated phenazine and acridine agents that induce rapid iron starvation in methicillin-resistant Staphylococcus aureus biofilms | |
| Mahey et al. | Pyrrole-based inhibitors of RND-type efflux pumps reverse antibiotic resistance and display anti-virulence potential | |
| Yang et al. | Antibacterial and antibiofilm formation activities of pyridinium-based cationic pillar [5] arene against Pseudomonas aeruginosa | |
| Başaran et al. | Extremophilic Natrinema versiforme against Pseudomonas aeruginosa quorum sensing and biofilm | |
| Liu et al. | Discovery of linear low-cationic peptides to target methicillin-resistant Staphylococcus aureus in vivo | |
| Shin et al. | Characterization of an antibacterial agent targeting ferrous iron transport protein FeoB against Staphylococcus aureus and Gram-positive bacteria | |
| Sturge et al. | AcrAB–TolC inhibition by peptide-conjugated phosphorodiamidate Morpholino oligomers restores antibiotic activity in vitro and in vivo | |
| Guo et al. | Discovery of unique bis-substituted aromatic amide derivatives as novel highly potent antibiotics for combating methicillin-resistant Staphylococcus aureus (MRSA) | |
| Yu et al. | Restoring and enhancing the potency of existing antibiotics against drug-resistant gram-negative bacteria through the development of potent small-molecule adjuvants | |
| Lee et al. | Synthesis and characterization of anguibactin to reveal its competence to function as a thermally stable surrogate siderophore for a gram-negative pathogen, Acinetobacter baumannii | |
| Marrujo et al. | Dimeric 2-aminoimidazoles are highly active adjuvants for gram-positive selective antibiotics against Acinetobacter baumannii | |
| Shaik et al. | Antifungal, anti-biofilm, and anti-hyphal properties of N-substituted phthalimide derivatives against Candida species | |
| Kavanaugh et al. | Di-berberine conjugates as chemical probes of Pseudomonas aeruginosa MexXY-OprM efflux function and inhibition | |
| Van Zuylen et al. | Disruption of metallostasis in the anaerobic human pathogen fusobacterium nucleatum by the zinc ionophore PBT2 | |
| Wang et al. | Design and characterization of a polyamine derivative inhibiting the expression of type III secretion system in Pseudomonas aeruginosa | |
| EP3484481A1 (en) | Methods for treatment ofclostridium difficile | |
| Blake et al. | Salicylanilide analog minimizes relapse of Clostridioides difficile infection in mice |